Avita Medical | 1811094D - Market Capitalization


Avita Medical reported AUD202.78M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Clinuvel Pharmaceuticals AUD 625.5M 105.22M Dec/2025
Cochlear AUD 7.9B 9.15B Aug/2026
CSL USD 60.19B 4.3B Aug/2026
Cspc Pharmaceutical CNY 99.86B 3.93B Aug/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 2.21T 464.84B Aug/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Mayne Pharma AUD 252.67M 153.55M Dec/2025
Medical Developments International AUD 37.11M 25.41M Aug/2026
Nanosonics AUD 963.21M 241.07M Aug/2026
Neuren Pharmaceuticals AUD 2.44B 80.57M Aug/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 5.1M 3.93M Aug/2026
Pacific Edge NZD 177.94M 16.27M Jun/2026
Paradigm Biopharmaceuticals AUD 61.46M 84.24M Aug/2026
Pharma Mar EUR 1.39B 78.26M Aug/2026
Polynovo AUD 849.74M 24.18M Dec/2025
PYC Therapeutics AUD 9.4B 8.44B Aug/2026
Qiagen NV USD 8.09B 182.39M Aug/2026
Ramsay Health Care AUD 10.02B 2.09B Aug/2026
ResMed USD 47.56B 4.96B Mar/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025
Zealand Pharma A/S 33.35B 12.51B Aug/2026